Chief Accounting Officer
Arcutis Biotherapeutics, Inc. (ARQT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Topper is recorded as CFO and Chief Accounting Officer at Arcutis Biotherapeutics, Inc. (ARQT). Arcutis Biotherapeutics, Inc. reported in an 8-K filed April 10, 2025 that David Topper retired as Chief Financial Officer, effective May 15, 2025. Arcutis Biotherapeutics, Inc. reported in an 8-K filed April 10, 2024 that David Topper was appointed principal accounting officer, effective April 10, 2024. Arcutis Biotherapeutics, Inc. reported in an 8-K filed April 10, 2024 that David Topper was appointed Chief Financial Officer, effective April 10, 2024. The proxy statement of Arcutis Biotherapeutics, Inc. reports total compensation of $1,946,733 for David Topper in fiscal 2025, including a base salary of $196,458. Disclosed compensation is on record for 2 fiscal years. David Topper has spoken on 4 earnings calls across 1 company, most recently for Arcutis Biotherapeutics, Inc. on January 13, 2025.
“Ms. Vairavan will succeed Mr. David Topper, who will transition out of his role as the Company's Chief Financial Officer and retire.”
“Consistent with the foregoing, Mr. Topper will assume the roles of principal financial officer and principal accounting officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-04-10–present
2024-04-10–present
2024-04-10–2025-05-15
Start not stated–2025-05-15
Recorded roles and call appearances connecting this person to public companies.
CFO, Chief Accounting Officer
2024-04-10–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Former Chief Financial Officer | $196,458 | $1,946,733 |
| 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Chief Financial Officer | $364,792 | $5,311,203 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
